Lightchain Capital
2 rounds tracked since 4 September 2025.
- Rounds
- 2
- Led
- 0
- Capital in these rounds
- $157M
Sectors
Countries
Rounds
- AI ProteinsAI-designed de novo miniprotein therapeutics $41.5MSeries A · 19 Nov
- WugenClinical-stage biotech developing donor-derived gene-edited CAR-T therapy for T-cell leukemia and lymphoma $115M4 Sept
No round matches these filters.